CKD with Cardiovascular Risk Factors Study

CKD with Cardiovascular Risk Factors Trials in Phoenix

Centricity Research is currently participating in a research study to look at how an investigational drug can be used to treat people with cardiovascular disease, chronic kidney disease, and inflammation. This study takes place at our Phoenix, AZ location. Chronic kidney disease (CKD) is associated with an increased risk for cardiovascular disease. Advances in drug therapy are key to treating this disease and preventing further damage.

Enroll Now

Join the ZEUS Clinical Trial

The objective of the ZEUS study is to demonstrate the superiority of an investigational drug compared to placebo, both added to standard of care, in participants with established atherosclerotic cardiovascular disease (ASCVD), chronic kidney disease, and systemic inflammation.

You maybe be eligible to participate in the ZEUS study if you are:

• at least 18 years old
• have chronic kidney disease
• have evidence of ASCVD such as coronary heart disease, cerebrovascular disease, or symptomatic peripheral artery disease (PAD)